Arteriosclerosis, Vol 10, 1-7, Copyright © 1990 by American Heart Association
ARTICLES |
G Di Minno and M Mancini
Istituto di Medicina Interna e Malattie Dismetaboliche, Universita degli Studi di Napoli, Italy.
Epidemiological observations indicate that high plasma fibrinogen levels are strongly correlated with the frequency of two major thrombotic complications of atherosclerosis, stroke and myocardial infarction. Thrombosis is increasingly recognized as a central mechanism in stroke and myocardial infarction, and fibrinogen is involved in events thought to play a major role in thrombosis. Therefore, elucidation of the relationship between fibrinogen and thrombosis may strengthen the predictive value of this protein and suggest new treatment to prevent stroke and myocardial infarction. The current data relating fibrinogen to thrombosis are not easy to reconcile with the available epidemiological observations. In addition, advances in understanding the atherogenic potential of several risk factors for coronary heart disease have used information on the measurement of the risk factors in population-based studies. Thus, measuring plasma fibrinogen to predict stroke and myocardial infarction may be important in gaining insight into the thrombogenic potential of this protein and in inspiring new strategies against the thrombotic complications of atherosclerosis.
This article has been cited by other articles:
![]() |
Y. Aono, T. Ohkubo, M. Kikuya, A. Hara, T. Kondo, T. Obara, H. Metoki, R. Inoue, K. Asayama, Y. Shintani, et al. Plasma Fibrinogen, Ambulatory Blood Pressure, and Silent Cerebrovascular Lesions: The Ohasama Study Arterioscler. Thromb. Vasc. Biol., April 1, 2007; 27(4): 963 - 968. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Feinbloom and K. A. Bauer Assessment of Hemostatic Risk Factors in Predicting Arterial Thrombotic Events Arterioscler. Thromb. Vasc. Biol., October 1, 2005; 25(10): 2043 - 2053. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kang, K. Chu, and J.-K. Roh POEMS Syndrome, Fibrinogen, and Ischemic Stroke: A Critical Point of View--Reply Arch Neurol, January 1, 2004; 61(1): 155 - 156. [Full Text] [PDF] |
||||
![]() |
D. G. Hackam and S. S. Anand Emerging Risk Factors for Atherosclerotic Vascular Disease: A Critical Review of the Evidence JAMA, August 20, 2003; 290(7): 932 - 940. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kang, K. Chu, D.-E. Kim, S.-W. Jeong, J.-W. Lee, and J.-K. Roh POEMS Syndrome Associated With Ischemic Stroke Arch Neurol, May 1, 2003; 60(5): 745 - 749. [Abstract] [Full Text] [PDF] |
||||
![]() |
K G M Moons, M L Bots, J T Salonen, P C Elwood, A Freire de Concalves, Y Nikitin, J Sivenius, D Inzitari, V Benetou, J Tuomilehto, et al. Prediction of stroke in the general population in Europe (EUROSTROKE): Is there a role for fibrinogen and electrocardiography? J Epidemiol Community Health, February 1, 2002; 56(90001): i30 - 36. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Parra Sleep-disordered breathing and stroke: is there a rationale for treatment? Eur. Respir. J., October 1, 2001; 18(4): 619 - 622. [Full Text] [PDF] |
||||
![]() |
A. S. M. Shamsuzzaman and V. K. Somers Fibrinogen, Stroke, and Obstructive Sleep Apnea . An Evolving Paradigm of Cardiovascular Risk Am. J. Respir. Crit. Care Med., December 1, 2000; 162(6): 2018 - 2020. [Full Text] |
||||
![]() |
M. Margaglione, R. Santacroce, D. Colaizzo, D. Seripa, G. Vecchione, M. R. Lupone, D. De Lucia, P. Fortina, E. Grandone, C. Perricone, et al. A G-to-A mutation in IVS-3 of the human gamma fibrinogen gene causing afibrinogenemia due to abnormal RNA splicing Blood, October 1, 2000; 96(7): 2501 - 2505. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Maresca, A. Di Blasio, R. Marchioli, and G. Di Minno Measuring Plasma Fibrinogen to Predict Stroke and Myocardial Infarction : An Update Arterioscler. Thromb. Vasc. Biol., June 1, 1999; 19(6): 1368 - 1377. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Kessler, C. Spitzer, D. Stauske, S. Mende, J. Stadlmuller, R. Walther, and R. Rettig The Apolipoprotein E and ß-Fibrinogen G/A-455 Gene Polymorphisms Are Associated With Ischemic Stroke Involving Large-Vessel Disease Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 2880 - 2884. [Abstract] [Full Text] |
||||
![]() |
A. Kaplan, S. Kaplan, K. F. Marcoe, L. R. Sauvage, and W. P. Hammond Identification of Potential Predisposition to Clinical Atherosclerosis: A Clinical Concept Based on Integration of Significant Blood Parameters with Platelet Aggregation Scores Clinical and Applied Thrombosis/Hemostasis, July 1, 1997; 3(3): 174 - 182. [Abstract] [PDF] |
||||
![]() |
H. E. Montgomery, P. Clarkson, O.M. Nwose, D.P. Mikailidis, I.A. Jagroop, C. Dollery, J. Moult, F. Benhizia, J. Deanfield, M. Jubb, et al. The Acute Rise in Plasma Fibrinogen Concentration With Exercise Is Influenced by the G-453-A Polymorphism of the ß-Fibrinogen Gene Arterioscler. Thromb. Vasc. Biol., March 1, 1996; 16(3): 386 - 391. [Abstract] [Full Text] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1990 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |